Get this at ₹ 14056Extra 5% OffAdd items worth ₹999 to the cart & get extra 5% off
Get this at ₹ 13316Extra 10% OffAdd items worth ₹1499 to the cart & get extra 10% off
Product Specifications
Book Summary
Given the increased attention by clinicians, researchers and the pharmaceutical
industry to the management and treatment of dementia not only in the elderly but
also in increasingly younger populations, the demands for effective
evidence-based pharmaceutical control of dementia and quantitative assessment of
outcomes have increased. Since some first steps in the early 1960's to the
controversial landmark paper of Summers and colleagues, to the most recent
trials, it is clear both that much progress has been made, and that much remains
to be done. This book is written to take stock of what is now usefully known,
and to speculate on directions for the future. Short Contents
ISBN-13
9781841843216
Language
English
Binding
Hard Bound
Publisher
Taylor & Francis Group / Spon Press
Publishing Date
2005-10-01
Product Edition
1
Trial Designs & Outcomes In Dementia Therapeutic Research
Given the increased attention by clinicians, researchers and the pharmaceutical
industry to the management and treatment of dementia not only in the elderly but
also in increasingly younger populations, the demands for effective
evidence-based pharmaceutical control of dementia and quantitative assessment of
outcomes have increased. Since some first steps in the early 1960's to the
controversial landmark paper of Summers and colleagues, to the most recent
trials, it is clear both that much progress has been made, and that much remains
to be done. This book is written to take stock of what is now usefully known,
and to speculate on directions for the future. Short Contents